North Dakota Medicaid and semaglutide
Wegovy for weight loss: no. Criteria cover reduction of major heart events, with age and BMI rules, and MASH. Ozempic for weight loss: unclear. The Weight Loss section of the coverage manual covers Ozempic injection for antipsychotic-induced weight gain, but its Obesity list does not name Ozempic. So it is not covered as a general obesity drug on these documents, yet a weight-related path exists for that one diagnosis.; for type 2 diabetes North Dakota Medicaid must cover it. Read from North Dakota Department of Health and Human Services, Medical Services Division documents Nov 6, 2026.
In 2025 North Dakota Medicaid paid for 1,627 semaglutide prescriptions (Ozempic, Rybelsus, Wegovy), 28% of its GLP-1 prescriptions and 50th of the 50 states and DC. It reimbursed $1.6 million before rebates, $970 a prescription against $1,104 nationally.
| Brand | Prescriptions | Medicaid paid | Per Rx |
|---|---|---|---|
| Ozempic | 1,616 | $1.6 million | $970 |
| Rybelsus | 11 | $10,763 | $978 |
| Wegovy | 0 | $0 | $NaN |
North Dakota plans and prescribing rules
NDPERS group health plan. North Dakota's NDPERS says GLP-1s are only available for the treatment of diabetes, not for weight loss, per its 2026 health insurance RFP answers and its October 2025 board materials.
Blue Cross Blue Shield of North Dakota. Blue Cross Blue Shield of North Dakota removed weight-loss drug coverage, GLP-1s included, from fully insured non-grandfathered large group plans starting January 1, 2026 at plan anniversary. Self-funded employers choose whether to include these drugs.
Semaglutide in the states around North Dakota
| State | Sell semaglutide, ship there | Cheapest | Medicaid Rx, 2025 | Medicaid, Wegovy for weight loss |
|---|---|---|---|---|
| North Dakota | 17 | $39/moWellmedr | 1,627 | Medicaid Wegovy: No |
| Minnesota | 19 | $39/moWellmedr | 165,896 | Medicaid Wegovy: Yes |
| Montana | 19 | $39/moWellmedr | 15,577 | Medicaid Wegovy: No |
| South Dakota | 19 | $39/moWellmedr | 7,210 | Medicaid Wegovy: No |



